Epstein A L, Kaplan H S
Cancer Res. 1979 May;39(5):1748-59.
Cell lines were successfully established in continuous suspension culture from 10 patients with a histopathological diagnosis of diffuse histiocytic lymphoma (SU-DHL-1 to SU-DHL-10), two with North American Burkitt's lymphoma (SU-AmB-1 and SU-AmB-2), and one with acute lymphoblastic leukemia (SU-ALL-1). By screening a variety of parameters, including media, sera, effusion fluids, feeder layers, and chemical supplements, the nutritive growth requirements of lymphoma cells obtained from malignant effusions and lymph node biopsies were determined for each tumor. Most of these cell lines initially required human skin fibroblast or epithelial cell feeder layers from which they could be weaned after one to six weeks in culture and maintained in Roswell Park Memorial Institute Tissue Culture Medium 1640 containing 20% fetal calf serum and 10% pooled human serum. Several of these cell lines were successfully cloned on 0.5% Noble agar substrates. In the presence of human serum and selected feeder monolayers, cloning efficiencies increased significantly from less than 1% to 15 to 25%. In addition, the cloning efficiencies of certain cell lines showed a concentration-dependent increase with specific chemical supplements including L-cysteine and dithiothreitol. Placental colony-stimulating factor, nerve growth factor, epithelial growth factor, and fibroblastic growth factor were ineffective in augmenting the cloning efficiencies of the human lymphoma cell lines. After a single passage on agar, cells subpassaged from visible colonies showed markedly increased cloning efficiencies to levels as high as 50%. Such cloning efficiencies, coupled with the use of replica plating, make this technique applicable to genetic and quantitative radiobiological, immunological, and chemotherapeutic studies. Although these methods have thus far been used only with lymphoreticular tumors, they may also be applicable to the cell culture of other human neoplasms and normal tissues.
从10例经组织病理学诊断为弥漫性组织细胞淋巴瘤(SU-DHL-1至SU-DHL-10)、2例北美伯基特淋巴瘤(SU-AmB-1和SU-AmB-2)以及1例急性淋巴细胞白血病(SU-ALL-1)患者中,成功建立了连续悬浮培养的细胞系。通过筛选多种参数,包括培养基、血清、积液、饲养层和化学添加剂,确定了从恶性积液和淋巴结活检中获得的淋巴瘤细胞对每种肿瘤的营养生长需求。这些细胞系大多数最初需要人皮肤成纤维细胞或上皮细胞饲养层,培养1至6周后可脱离饲养层,并在含有20%胎牛血清和10%混合人血清的罗斯韦尔帕克纪念研究所组织培养基1640中维持培养。其中一些细胞系在0.5%诺布尔琼脂底物上成功克隆。在人血清和选定的饲养单层存在的情况下,克隆效率从低于1%显著提高到15%至25%。此外,某些细胞系的克隆效率随着包括L-半胱氨酸和二硫苏糖醇在内的特定化学添加剂呈浓度依赖性增加。胎盘集落刺激因子、神经生长因子、上皮生长因子和成纤维细胞生长因子在提高人淋巴瘤细胞系的克隆效率方面无效。在琼脂上进行一次传代后,从可见菌落传代的细胞克隆效率显著提高,高达50%。这种克隆效率,再加上使用复制平板法,使该技术适用于遗传和定量放射生物学、免疫学及化疗研究。尽管这些方法迄今为止仅用于淋巴网状肿瘤,但它们也可能适用于其他人类肿瘤和正常组织的细胞培养。